These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3863217)

  • 81. Inoculum effect of beta-lactam antibiotics on Enterobacteriaceae.
    Eng RH; Cherubin C; Smith SM; Buccini F
    Antimicrob Agents Chemother; 1985 Nov; 28(5):601-6. PubMed ID: 4091525
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Epidemiology of fecal strains of the family Enterobacteriaceae in 22 neonatal wards and influence of antibiotic policy.
    Tullus K; Berglund B; Fryklund B; Kühn I; Burman LG
    J Clin Microbiol; 1988 Jun; 26(6):1166-70. PubMed ID: 3384927
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit.
    Prevot MH; Andremont A; Sancho-Garnier H; Tancrede C
    Antimicrob Agents Chemother; 1986 Dec; 30(6):945-7. PubMed ID: 3813517
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis.
    Boscia JA; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1985 May; 27(5):708-11. PubMed ID: 3860186
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Non-specific influence of antibiotics on the course of infectious processes.
    Gillissen G
    Infection; 1982; 10(3):128-30. PubMed ID: 6286499
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparative study of serum bactericidal activity of cefotaxime alone or in combination with tobramycin.
    Bergeron MG; LeBel M; Charest A; Forcier JF; Morin J; Vallée F
    Antimicrob Agents Chemother; 1986 Feb; 29(2):379-81. PubMed ID: 3087282
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis.
    Dhondt A; Vanholder R; Waterloos MA; Glorieux G; De Smet R; Ringoir S
    Infection; 1998; 26(2):120-5. PubMed ID: 9561384
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pharmacokinetics of cefotaxime, moxalactam, and cefoperazone in the early puerperium.
    Charles D; Larsen B
    Antimicrob Agents Chemother; 1986 May; 29(5):873-6. PubMed ID: 3729345
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The relationship between resistance in bacteria and antibiotic use in neurology and haematology units.
    Krupova Y; Gould JC
    Int J Antimicrob Agents; 2000 Sep; 16(1):79-80. PubMed ID: 10958575
    [No Abstract]   [Full Text] [Related]  

  • 90. Activity of cefotiam in combination with beta-lactam antibiotics on enterobacterial hospital strains.
    Vanhoof R; Hubrechts JM; Nyssen HJ; Nulens E; Leger J; de Schepper N; Kupperberg E; Couvreur ML
    Pharm Weekbl Sci; 1990 Jun; 12(3):104-6. PubMed ID: 2371139
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
    Boscia JA; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1987 Mar; 31(3):458-60. PubMed ID: 3472489
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Elimination of bacteria in biliary tract infections during ceftizoxime therapy.
    Helm EB; Wurbs D; Haag R; Bentele D; Shah PM
    Infection; 1982; 10(2):67-70. PubMed ID: 6284649
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes.
    Hand WL; King-Thompson N; Holman JW
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1553-7. PubMed ID: 3481246
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Clissold SP; Todd PA; Campoli-Richards DM
    Drugs; 1987 Mar; 33(3):183-241. PubMed ID: 3552595
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Influence of beta-lactam antibiotics on serum resistance of K1-positive blood culture isolates of Escherichia coli.
    Suerbaum S; Leying H; Meyer B; Opferkuch W
    Antimicrob Agents Chemother; 1990 Apr; 34(4):628-31. PubMed ID: 2188587
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Influence of imipenem on the serum resistance of enterobacteriaceae.
    Wiemer CW; Kubens B; Opferkuch W
    Rev Infect Dis; 1985; 7 Suppl 3():S426-31. PubMed ID: 3863217
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
    Neu HC
    Annu Rev Pharmacol Toxicol; 1982; 22():599-642. PubMed ID: 6282190
    [No Abstract]   [Full Text] [Related]  

  • 98. [Action of imipenem on Enterobacter cloacae].
    Donnio PY; Lebert P; Travert MF; Avril JL
    Pathol Biol (Paris); 1988 May; 36(5):456-9. PubMed ID: 3043343
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
    Bompard Y; Lambert T; Gantzer A; Chastel A; Voinnesson A; Aufrant C
    Pathol Biol (Paris); 1988 May; 36(5):521-4. PubMed ID: 3043351
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
    Schröter G; Schrettenbrunner A; Strenzel I
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.